205194-35-0

Usage

Uses

Used in Organic Synthesis:
3-Piperidinemethanol,1-methyl-,(3S)-(9CI) is used as a building block in organic synthesis for the creation of various biologically active compounds. Its unique structure and reactivity make it a valuable component in the synthesis of complex organic molecules.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 3-Piperidinemethanol,1-methyl-,(3S)-(9CI) is used as a key intermediate in the development of new drugs. Its potential role in medicinal chemistry is attributed to its ability to form the backbone of various pharmaceutical agents, contributing to the discovery of novel therapeutics.
Used in Agrochemical Development:
3-Piperidinemethanol,1-methyl-,(3S)-(9CI) may also find applications in the agrochemical sector, where it could be employed in the synthesis of new pesticides or other agrochemicals. Its potential use in this field is due to its capacity to be incorporated into molecules with bioactive properties that can be utilized in agricultural settings.
It is crucial to handle 3-Piperidinemethanol,1-methyl-,(3S)-(9CI) with care due to its potential hazards if not properly managed, ensuring safety in its applications across different industries.

InChI:InChI=1/C7H15NO/c1-8-4-2-3-7(5-8)6-9/h7,9H,2-6H2,1H3/t7-/m0/s1

Upstream product

• 140695-84-7 tert-butyl (3S)-3-(hydroxymethyl)piperidine-1-carboxylate 
• 1346514-04-2 ethyl N-carbethoxy-piperidine-3S-carboxylate 

Downstream Products

• 205193-44-8 (S)-4-(4-chloro-2-fluoroanilino)-6-methoxy-7-(1-methylpiperidin-3-yl)methoxyquinazoline 
• 1159598-45-4 [(3S)-1-methylpiperidin-3-yl]methyl 4-(4-methylphenyl)piperazine-1-carboxylate 

Relevant academic research and scientific papers

AMINOESTER DERIVATIVES

The invention relates to novel compounds which are both phosphodiesterase 4 (PDE4) enzymeinhibitorsand muscarinic M3 receptor antagonists, methods of preparing such compounds, compositions containing them and therapeutic use thereof.

THE (S)-ENANTIOMER OF MEPAZINE

The present invention relates to the (S)-enantiomer of mepazine, its applicability in therapy, a pharmacological composition comprising (S)-mepazine, and processes for the preparation of (S)- mepazine and one of its intermediates.

Structural analysis of phenothiazine derivatives as allosteric inhibitors of the MALT1 paracaspase

Second site: In the crystal structure of human MALT1casp-Ig3 (mucosa-associated lymphoid tissue lymphoma translocation protein 1) in complex with the tricyclic phenothiazine derivative thioridazine (violet in the picture), the inhibitor is bound in a hydrophobic pocket far from the active site. This explains the action of phenothiazine derivatives as noncompetitive, reversible inhibitors. Copyright

PIPERAZINES AS ANTI-OBESITY AGENTS

The present invention relates to new compounds of formula (I), to pharmaceutical compositions comprising these compounds, to processes for their preparation, and to the use of these compounds as leptin receptor modulator mimetics in the preparation of medicaments against conditions associated with weight gain, type 2 diabetes and dyslipidemias.

METHODS OF USE FOR INHIBITORS OF AKT ACTIVITY

Invented is the use of 1 H-imidazo[4,5-c]pyridin-2-yl compounds in the treatment of specified cancers.

INHIBITORS OF AKT ACTIVITY

Invented are novel 1 H-imidazo[4,5-c]pyridin-2-yl compounds, the use of such compounds as inhibitors of protein kinase B activity and in the treatment of cancer and arthritis.

N-HETEROCYCLYL-SUBSTITUTED AMINO-THIAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS

Aminothiazole compounds with N-containing cycloalkyl at the 2-amino position which are represented by the Formula (I), or a pharmaceutically acceptable prodrug of said compound, or pharmaceutically acceptable salt of said compound, modulate and/or inhibit the cell proliferation and activity of protein kinases.